Acute lymphoblastic leukemias correspond to a very heterogeneous disease with various genetic abnormalities. It remains the most common form of childhood cancer and the leading cause of cancer death before the age of 20.
In acute lymphoblastic leukemia, the last few years have been marked by an incredible improvement in survival, going from 10% in the 1960s to 90% in the 2000s. Above all, these advances have been obtained with a decrease in complications. long term thanks to the stratification of patients and the personalization of treatments. Professor Mohamad Mohty, onco-hematologist and head of department at Saint-Antoine hospital in Paris, answers our questions in a program with Dr Jean-François Lemoine.
.
